Cargando…

Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity

The diagnostic landscape of non-small cell lung cancer (NSCLC) is changing rapidly with the availability of novel treatments. Despite high-level healthcare in the Netherlands, not all patients with NSCLC are tested with the currently relevant predictive tumor markers that are necessary for optimal d...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Broek, Daan, Hiltermann, T. Jeroen N., Biesma, Bonne, Dinjens, Winand N. M., 't Hart, Nils A., Hinrichs, John W. J., Leers, Mathie P. G., Monkhorst, Kim, van Oosterhout, Matthijs, Scharnhorst, Volkher, Schuuring, Ed, Speel, Ernst-Jan M., van den Heuvel, Michel M., van Schaik, Ron H. N., von der Thüsen, Jan, Willems, Stefan M., de Visser, Leonie, Ligtenberg, Marjolijn J. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987414/ https://www.ncbi.nlm.nih.gov/pubmed/32039011 http://dx.doi.org/10.3389/fonc.2019.01521

Ejemplares similares

“The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor
por: Dinjens, Winand N. M., et al.
Publicado: (2020)

In‐depth molecular analysis of combined and co‐primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma
por: Hermans, Bregtje C. M., et al.
Publicado: (2021)

Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations
por: Koopman, Bart, et al.
Publicado: (2020)

Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics
por: Eijkelenboom, Astrid, et al.
Publicado: (2019)

Development and validation of an early warning score to identify COVID-19 in the emergency department based on routine laboratory tests: a multicentre case–control study
por: Boer, Arjen-Kars, et al.
Publicado: (2022)

Use of an algorithm based on routine blood laboratory tests to exclude COVID-19 in a screening-setting of healthcare workers
por: Leers, Math P. G., et al.
Publicado: (2022)

Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
por: van den Heuvel, Guus R. M., et al.
Publicado: (2021)

Functional Polymorphisms Associated with Disease-Free Survival in Resected Carcinoma of the Esophagus
por: Boonstra, Jurjen J., et al.
Publicado: (2010)

Mucinous carcinoid of the ovary: report of a case with metastasis in the contralateral ovary after ten years
por: Buis, Christien C.M, et al.
Publicado: (2010)

Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC
por: Schuurbiers, Milou, et al.
Publicado: (2022)

Functional characterisation of a novel class of in-frame insertion variants of KRAS and HRAS
por: Eijkelenboom, Astrid, et al.
Publicado: (2019)

Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer
por: Saber, Ali, et al.
Publicado: (2016)

Excluding Lynch syndrome in a female patient with metachronous DNA mismatch repair deficient colon- and ovarian cancer
por: Crobach, Stijn, et al.
Publicado: (2017)

Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing
por: Pruis, Melinda A., et al.
Publicado: (2022)

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer
por: Schouten, Robert D., et al.
Publicado: (2021)

Risk Factors for Introduction of Bovine Herpesvirus 1 (BoHV-1) Into Cattle Herds: A Systematic European Literature Review
por: Waldeck, H. W. Frederik, et al.
Publicado: (2021)

Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
por: Derks, Jules L, et al.
Publicado: (2019)

Invasive Pulmonary Aspergillosis with Marked Eosinophilia as a Unique Presentation of Chronic Granulomatous Disease
por: Van Woensel, Julie, et al.
Publicado: (2022)

Early onset esophageal adenocarcinoma: a distinct molecular entity?
por: van Nistelrooij, Anna M.J., et al.
Publicado: (2016)

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance
por: Koole, Simone N., et al.
Publicado: (2022)

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions
por: Hummelink, Karlijn, et al.
Publicado: (2019)

Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung Cancers
por: Wei, Jiacong, et al.
Publicado: (2018)

Sensitive detection and quantification of SARS-CoV-2 by multiplex droplet digital RT-PCR
por: de Kock, Remco, et al.
Publicado: (2020)

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients
por: Vessies, Daan C. L., et al.
Publicado: (2022)

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
por: Groenendijk, Floris H., et al.
Publicado: (2010)

The effectiveness of bovine tuberculosis surveillance in Dutch badgers
por: Orrico, Mario, et al.
Publicado: (2021)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
por: van Haren, Frank, et al.
Publicado: (2021)

Modelling the reproductive power function
por: van den Broek, Jan
Publicado: (2020)

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
por: Synhaeve, Nathalie E., et al.
Publicado: (2018)

Novel EGFR V834L Germline Mutation Associated With Familial Lung Adenocarcinoma
por: van der Leest, Cor, et al.
Publicado: (2018)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
por: Steendam, Christi M. J., et al.
Publicado: (2020)

Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma
por: Theelen, W. S. M. E., et al.
Publicado: (2020)

Evaluating the Application of the Mental Model Mapping Tool (M-Tool)
por: van den Broek, Karlijn L., et al.
Publicado: (2021)

Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing
por: Saber, Ali, et al.
Publicado: (2016)

A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer
por: Alves, Inês Teles, et al.
Publicado: (2016)

Completing the Enalaprilat Excretion Pathway—Renal Handling by the Proximal Tubule
por: Smeets, Nori J. L., et al.
Publicado: (2020)

Left atrial reservoir strain as a predictor of cardiac outcome in patients with heart failure: the HaFaC cohort study
por: Bouwmeester, Sjoerd, et al.
Publicado: (2022)

Prognostic Value of Combined Biomarkers in Patients With Heart Failure: The Heartmarker Score
por: van der Stam, Jonna A., et al.
Publicado: (2023)

Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome
por: Geurts‐Giele, Willemina R., et al.
Publicado: (2019)

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
por: Derks, Jules L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bnmd244171p242sn0sn38pk4p0